ASK REDCHAT ANYTHING ABOUT MESOBLAST LIMITED
Mesoblast Limited (NASDAQ: MESO)
Listen to this Section
$14.49
-1.0600
(
-6.82% )
277.7K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| RexlemestrocelDetailsChronic lower back pain |
Phase 3 |
| Remestemcel-LDetailsInflammatory bowel disease, Bowel disorder, Crohns disease |
Failed |
| Remestemcel-L (mesenchymal stem cells)DetailsCOVID-19 |
Failed |
Market Data
|
| Open |
$14.49 |
| Previous Close |
$15.55 |
| Volume |
277.7K |
| Market Cap |
$2.01B |
| Day Range |
$14.21 - $15.43 |
| 52 Week Range |
$10.32 - $21.50 |
| Shares Outstanding |
129.28M |
| Change % |
-6.82% |
| Net Change |
▼ -1.0600 |
| Insider Ownership |
N/A |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2009 |
| Country | Australia |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
0.00
| Date |
Type |
Amount Purchased |
Purchaser |
| No records found. |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 6-k |
Form 6-K |
5 |
Nov 05, 2025 |
| 6-k |
Form 6-K |
11 |
Oct 29, 2025 |
| 6-k |
Form 6-K |
329 |
Oct 28, 2025 |
| 6-k |
Form 6-K |
11 |
Oct 22, 2025 |
| 6-k |
Form 6-K |
25 |
Oct 15, 2025 |
| 6-k |
Form 6-K |
4 |
Oct 07, 2025 |
| 6-k |
Form 6-K |
4 |
Oct 03, 2025 |
| 6-k |
Form 6-K |
4 |
Sep 29, 2025 |
| 6-k |
Form 6-K |
5 |
Sep 15, 2025 |
| 6-k |
Form 6-K |
4 |
Sep 15, 2025 |